Source: Jill Lawless The Associated Press, globalnews.ca, April 12, 2021
Last month, Pfizer said, during a clinical trial, the vaccine was found to be safe, effective and produced robust antibody responses in 12 to 15-year-olds.
Pharmaceutical giant Pfizer is planning to submit the necessary documents to Health Canada “in the next couple of weeks” to seek approval for its COVID-19 vaccine to be used in children between the ages of 12 and 15, a company spokesperson has confirmed.
In an email to Global News on Sunday, Pfizer spokesperson Christina Antoniou, said the company is “currently working on our submission supporting the use of the vaccine in 12-15 year olds.”
For the latest information and for more updates on everything Kindersley ‘Like’ the Kindersley Social Facebook page below…